Suven Of India Still Seeks Global Phase II Partner For Mental Drug
This article was originally published in PharmAsia News
Executive Summary
India's Suven Life Sciences is seeking, so far without success, a foreign partner to help it conduct clinical trials on a drug it is developing to treat schizophrenia and Alzheimer's disease